Results 211 to 220 of about 5,853,531 (371)

Conflicts of Interest in Medical Writing and the Concept of Disclosure

, 2000
Mark B. Constantian
openalex   +1 more source

Specifying conflict of interest in web services endpoint language (WSEL) [PDF]

, 2002
Patrick C. K. Hung
openalex   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Authorship & Conflict of Interest Statement

Journal of Dental Sciences, 2015
doaj   +1 more source

Adoption of the voluntary conflict of interest statement on PubMed. [PDF]

PLoS One
Rogus S, Ross JS, Lurie P.
europepmc   +1 more source

Social Media and Physician Conflict of Interest.

American Journal of Medicine, 2018
Cian P. McCarthy, M. Decamp, J. McEvoy
semanticscholar   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Institutional Conflict of Interest Policies at U.S. Academic Research Institutions

Academic medicine : journal of the Association of American Medical Colleges, 2016
D. Resnik, J. Ariansen, Jaweria Jamal, G. Kissling   +3 more
semanticscholar   +1 more source

Proposed Rules Aim to Curb Financial Conflicts of Interest [PDF]

, 2002
Jocelyn Kaiser
openalex   +1 more source